CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

The Use of Transdermal Buprenorphine in Adults: Safety

Last updated: July 20, 2015
Project Number: RA0788-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report


  1. What is the clinical evidence on the harms associated with transdermal buprenorphine, including misuse and abuse?

Key Message

Three systematic reviews, four randomized controlled trials, and four non-randomized studies were identified regarding the safety of transdermal buprenorphine patches.